Skip to main content
Premium Trial:

Request an Annual Quote

ZPredicta, LabCorp Form Cancer Cell Culture Model Partnership

NEW YORK — ZPredicta said on Thursday that it has partnered with Laboratory Corporation of America to develop and commercialize tumor-specific preclinical models based on its 3D cell culture platform.

ZPredicta's platform integrates organ-specific cellular and extracellular elements into 3D culture models for in vitro cancer drug testing. The San Jose, California-based company said that the alliance with LabCorp will help expand the platform's use for preclinical testing and research studies.

Specific terms of the deal were not disclosed.

"LabCorp is one of the world’s leading life science companies and its drug development business, Covance, is one of the leading end-to-end development partners for the biopharmaceutical industry," ZPredicta Founder and CEO Julia Kirshner said in a statement. "With this strategic relationship, we are well positioned to offer our cell culture technology to a much larger customer base and also to expand the number of cell culture models that we offer."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.